Carbidopa/levodopa

Developed for: cognitive disorder · depressive disorder
Investigated by: Columbia University · Emory University · National Institute of Mental Health (NIMH) · New York State Psychiatric Institute · Vanderbilt University Medical Center

today NCT04493320 · Ph 4

202120222023202420252026

Phase	Registry id	Dates	Indication	Sponsor	Status	Outcome
Phase 4	NCT04493320	Feb → Oct 2021	cognitive disorder, depressive disorder	New York State Psychiatric Institute	Terminated	No outcome recorded

Every value below carries the sentence it was read from. 1 source stands behind the page.

Field	Value	Cited text
Known as	Carbidopa/levodopa	ClinicalTrials.gov intervention name — accepted as the source's own label NCT04493320 ↗